Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
- PMID: 37212317
- PMCID: PMC10266714
- DOI: 10.1002/jmv.28773
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Abstract
This review will provide an overview of the notion that Kaposi sarcoma (KS) is a disease that manifests under diverse and divergent circumstances. We begin with a historical introduction of KS and KS-associated herpesvirus (KSHV), highlight the diversity of clinical presentations of KS, summarize what we know about the cell of origin for this tumor, explore KSHV viral load as a potential biomarker for acute KSHV infections and KS-associated complications, and discuss immune modulators that impact KSHV infection, KSHV persistence, and KS disease.
Keywords: KSHV; Kaposi sarcoma; herpesvirus.
© 2023 Wiley Periodicals LLC.
Conflict of interest statement
Conflict of Interest
The authors declare no conflicts.
Figures
References
-
- Centers for Disease C Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30(25):305–308. - PubMed
-
- Maurer T, Ponte M, Leslie K. HIV-associated Kaposi’s sarcoma with a high CD4 count and a low viral load. N Engl J Med. 2007;357(13):1352–1353. - PubMed
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
